Detection of soluble Fas mRNA using in situ reverse transcription- polymerase chain reaction

Laboratory Investigation

Volumn 78, Issue 4, 1998, Pages 453-459

  Lee, Sug Hyung ^a   Kim, Su Young ^a   Lee, Jung Young ^a   Shin, Min Sun ^a   Dong, Seung Myung ^a   Na, Eun Young ^a   Park, Won Sang ^a   Kim, Kyung Mi ^a   Kim, Choo Soung ^a   Kim, Sang Ho ^a   Yoo, Nam Jin ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; MESSENGER RNA;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TISSUE DISTRIBUTION; TUMOR CELL;

ALTERNATIVE SPLICING; ANTIGENS, CD95; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 0001393719     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Artero RD, Akam M, and Perez-Alonso M (1992). Oligonucleotide probes detect splicing variants in situ in Drosophila embryos. Nucleic Acids Res 20:5687-5690.
2. Backer-Cairns B, Meyers K, Hamilton R, Smith C, and Tornatore C (1996). Immunohistochemical staining of fixed tissue using antigen retrieval and a thermal cycler. Biotechniques 20:641-650.
3. Breitbart RE, Andreadis A, and Nadal-Ginard B (1987). Alternative splicing: A ubiquitous mechanism for the generation of multiple protein isoforms from single genes. Annu Rev Biochem 56:467-495.
4. Cascino I, Fiucci G, Papoff G, and Ruberti G (1995). Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 154:2706-2713.
5. Chen RH and Fuggle SV (1993). In situ cDNA polymerase chain reaction: A novel technique for detecting mRNA expression. Am J Pathol 143:1527-1534.
6. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, and Mountz JD (1994). Protection from Fasmediated apoptosis by a soluble form of the Fas molecule. Science 263:1759-1762.
7. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini J-C, and Tschopp J (1996). Melanoma cell expression on Fas (Apo-1/CD95) ligand: Implications for tumor immune escape. Science 274:1363-1366.
8. Hayashi H, Tatebe S, Osaki M, Goto A, Suzuki Y, and Ito H (1997). Expression of Fas antigen and its mediation of apoptosis in human gastric cancer cell lines. Jpn J Cancer Res 88:49-55.
9. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroeter M, Burns K, Mattmann C, Rimoldi D, French LE, and Tschopp J (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195.
10. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, and Nagata S (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243.
11. Kerstens HMJ, Poddighe PJ, and Hansellar AGJM (1995). A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramide. J Histochem Cytochem 43:347-352.
12. Knipping E, Debatin K-M, Stricker K, Heilig B, Eder A, and Krammer PH (1995). Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemia. Blood 85:1162-1169.
13. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin K-M, Krammer PH, and Moller P (1993). Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69:415-429.
14. Liu C, Cheng J, and Muontz JD (1995). Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem J 310:957-963.
15. Midis GP, Shen Y, and Owen-Schaub LB (1996). Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy. Cancer Res 56:3870-3874.
16. Moller P, Kortez K, Leithauser F, Bruderlein S, Henne C, Quentmeier A, and Krammer PH (1994). Expression of APO-1 (CD95), a member of the TNF/NGF receptor superfamily, in normal and neoplastic colon epithelium. Int J Cancer 57:371-377.
17. Nagata S (1994). Fas and Fas ligand: A death factor and its receptor. Adv Immunol 57:129-144.
18. Natoli G, Ianni A, Costanzo A, Petrillo GD, Ilari I, Chirillo P, Balsano C, and Levrero M (1995). Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 11:1157-1164.
19. Nuovo GJ (1994). PCR in situ hybridization: Protocols and applications. New York: Raven Press.
20. O'Leary JJ, Chetty R, Graham AK, and McGee JO (1996). In situ PCR: Pathologist's dream or nightmare? J Pathol 178: 11-20.
21. Owen-Schaub LB, Angelo LS, Radinsky R, Ware CF, Gesner TG, and Bartos DP (1995). Soluble Fas/APO-1 in tumor cells: A potential regulator of apoptosis? Cancer Lett 94:1-8.
22. Papoff G, Cascino I, Eramo A, Starace G, Lynch DH, and Ruberti G (1996). An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. J Immunol 156:4622-4630.
23. Peters J, Krams M, Wacker HH, Carstens A, Weisner D, Hamann K, Menke M, Harms D, and Parwaresch R (1997). Detection of rare RNA sequences by single-enzyme in situ reverse transcription-polymerase chain reaction. Am J Pathol 150:469-476.
24. Sato T, Irie S, Kituda S, and Reed JC (1995). FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 268:411-415.
25. Steel JH and Poulsom R (1997). Making sense out of in situ PCR. J Pathol 182:11-12.
26. Suda T and Nagata S (1994). Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179:873-879.
27. Suda T, Takahashi T, Golstein P, and Nagata S (1993). Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178.
28. Tanzi RE, Wenniger JJ, and Hyman BT (1993). Regional distribution and cellular specificity of AAP alternative transcripts are unaltered in Alzheimer's disease and control hippocampal formation. Mol Brain Res 18:253-258.
29. Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, Debatin KM, and Krammer PH (1989). Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305.
30. Weller M, Malipielo U, Rensing-Ehl A, Barr PJ, and Fontana A (1995). Fas/APO-1 gene transfer for human malignant glioma. Cancer Res 55:2936-2944.
31. Yonehara S, Ishii A, and Yonehara M (1989). A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747-1756.